Atlas Trials

Preventing Inhibitor Recurrence Indefinitely

Clinical trial NCT04621916 · UNKNOWN

Trial details

NCT number
NCT04621916
Sponsor
Children's Hospital Los Angeles
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hemophilia AImmune Tolerance
Start date
2020-09-21
Primary completion
2024-09-20
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.